Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Cryofocus Medtech (Shanghai) Co. Ltd. Class H ( (HK:6922) ) is now available.
Cryofocus Medtech (Shanghai) Co., Ltd. has announced its 2025 first extraordinary general meeting to discuss significant corporate governance changes. Key resolutions include amending the Articles of Association, abolishing the Supervisory Committee, and revising the rules of procedure for board and shareholders’ meetings, potentially impacting the company’s governance structure and operational efficiency.
More about Cryofocus Medtech (Shanghai) Co. Ltd. Class H
Cryofocus Medtech (Shanghai) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the medical technology industry. The company is involved in developing and providing innovative medical solutions.
Average Trading Volume: 134,358
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.55B
For a thorough assessment of 6922 stock, go to TipRanks’ Stock Analysis page.